Concepedia

Jennifer Tullai

JT

11

Publications

657

Citations

11

H-Index

1993

Active since

Affiliations

Johnson & Johnson (United States)(Current)

Novartis (United States)

Novartis (Switzerland)

Scripps Research Institute

Jennifer Tullai is an author at Johnson & Johnson (United States) specializing in cell biology, biochemistry, and medicine.

Top concepts

Publications per year

1993–2025

11

Publications

11

Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy

Simone Bonazzi, Eva d’Hennezel, Rohan E. J. Beckwith et al. · Cell chemical biology · 2023 · 135 citations · Full text

Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation

Cheryl Carson, Pichai Raman, Jennifer Tullai et al. · PLoS ONE · 2015 · 108 citations · Full text

, , +16

Identification of a 13 Amino Acid Peptide Mimetic of Erythropoietin and Description of Amino Acids Critical for the Mimetic Activity of EMP1

Dana L. Johnson, Francis X. Farrell, Francis P. Barbone et al. · Biochemistry · 1998 · 101 citations

, , +14

Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor–positive breast carcinoma models

Kenneth R. LaMontagne, Jeannene Butler, Deborah J. Marshall et al. · Molecular Cancer Therapeutics · 2006 · 81 citations · Full text

Shared and Unique Determinants of the Erythropoietin (EPO) Receptor Are Important for Binding EPO and EPO Mimetic Peptide

Steven A. Middleton, Francis P. Barbone, Dana L. Johnson et al. · Journal of Biological Chemistry · 1999 · 60 citations · Full text

Rows per page

1–5 of 11